search
Back to results

Pre-operative Ultrasonographic Evaluation of the Internal Jugular Vein Collapsibility Index and Inferior Vena Cava Collapsibility Index to Predict Post Spinal Hypotension in Pregnant Women Undergoing Caesarean Section

Primary Purpose

Cesarean Section

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
US Internal Jugular Vein Collapsibility Index measurment
US Inferior Vena Cava Collapsibility Index measurment
Sponsored by
Tanta University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Cesarean Section focused on measuring cesarean section, hypotension

Eligibility Criteria

20 Years - 40 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

1.55 female patients 2. aged 20-40 years 3.ASA Physical Status Class I and II 4. scheduled for elective lower segment cesarean section

Exclusion Criteria:

  1. Patients who will refuse
  2. Emergency LSCS
  3. Patients with expected massive intraoperative blood loss e.g. placenta Previa and placenta accreta
  4. Cardiovascular, respiratory, renal diseases
  5. Patients who will receive preloading of intravenous fluid

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Experimental

    Arm Label

    US Internal Jugular Vein Collapsibility Index

    US Inferior Vena Cava Collapsibility Index

    Arm Description

    The US transducer will be placed on the right side of the neck in the transverse plane over RIJV 2 cm above the sternoclavicular joint. The IJV will be identified by the color flow Doppler and compressibility.

    The transducer will be placed in the subxiphoid region in a longitudinal position. IVC measurements will be made just distal to the IVC-hepatic vein junction, approximately 3 to 4 cm distal to the right atrium. The IVC will be identified by Doppler waveform, compressibility and phasic collapse with respiration.

    Outcomes

    Primary Outcome Measures

    pre-operative inferior vena cava collapsibility index (IVCCI)
    for predicting post-spinal anaesthesia hypotension (PSAH). The maximum (IVCD) and minimum (IVCD) internal anteroposterior (AP) diameters of the IVC at the end of expiration and inspiration respectively over the same respiratory cycle will be measured. The IVCCI is derived from the equation, IVCCI= (IVCD max -IVCD min)/IVCD max × 100
    pre-operative internal jugular vein collapsibility index (IJVCI)
    for predicting post-spinal anaesthesia hypotension (PSAH), The maximum, minimum antero-pestorior diameters, and cross-sectional area will be estimated and, from this, corresponding collapsibility index will be derived (Maximum diameter or cross-sectional area (CSA)-minimum diameter or CSA/maximum diameter or CSA) ×100%.

    Secondary Outcome Measures

    Full Information

    First Posted
    August 17, 2020
    Last Updated
    October 26, 2020
    Sponsor
    Tanta University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04519996
    Brief Title
    Pre-operative Ultrasonographic Evaluation of the Internal Jugular Vein Collapsibility Index and Inferior Vena Cava Collapsibility Index to Predict Post Spinal Hypotension in Pregnant Women Undergoing Caesarean Section
    Official Title
    Pre-operative Ultrasonographic Evaluation of the Internal Jugular Vein Collapsibility Index and Inferior Vena Cava Collapsibility Index to Predict Post Spinal Hypotension in Pregnant Women Undergoing Caesarean Section
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    August 2020
    Overall Recruitment Status
    Unknown status
    Study Start Date
    October 30, 2020 (Anticipated)
    Primary Completion Date
    November 1, 2020 (Anticipated)
    Study Completion Date
    December 1, 2020 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Tanta University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    Postspinal hypotension (PSH) is common in obstetric anesthesia practice, with an incidence of up to 71 %. PSH can occur precipitously and, if severe, can result in both maternal and fetal/neonatal adverse events. Pregnant women with predelivery hypovolemia are at risk of cardiovascular collapse and the sympathetic blockade may severely decrease venous return. Hence, prevention of PSH is an essential element in obstetric anesthesia and fasting for aspiration prophylaxis may further add up to the hypovolemia for the patients not on maintenance fluids. Hemodynamic monitoring in obstetric patients has evolved during the last decade, with the development of minimally invasive and noninvasive continuous cardiac output (CO) monitors. Ultrasound (USG) is a method for noninvasive hemodynamic optimization in the ICU and ED, and it may be more helpful than other noninvasive methods. Transabdominal USG measurements of inferior vena cava (IVC) are noninvasive and thus are not associated with complications. USG of the IVC diameter is a useful and easy method for assessing a patient's volume status by calculating the IVC collapsibility index (IVCCI). Recently, the usefulness of point-of-care ultrasonographic examination, performed by anesthesiologists in real time, for perioperative management has been reported . Ultrasonographic studies have established the utility of measuring the inferior vena cava (IVC) or internal jugular Vein (IJV) for evaluating intravascular volume status . In particular, IVC diameter and collapsibility, obtained from ultrasonographic measurement, have been demonstrated to be predictors of hypotension after anesthetic administration.
    Detailed Description
    Pregnant women planned for elective surgery will be advised for nil per oral after midnight and. After detailed preanesthetic checkup, on arrival in operating room, standard monitoring devices will be attached (pulse oximeter, noninvasive blood pressure and 3-lead electrocardiography). Machine A sonosite M-Turbo ultrasound machine will be used for all the examinations. A curvilinear USG probe for IVC imaging (1-5 MHz, 21 mm). A linear vascular transuder for IJV imaging (7-13 MHz, 38 mm) will be used. Measurements IJV measurement All the measurements will be done on Right IJV with the patients initially lying supine at 0° and later head end elevated at 30°. With the patients in supine position, the USG transducer will be placed on the right side of the neck in the transverse plane over RIJV 2 cm above the sternoclavicular joint. The IJV will be identified by the color flow Doppler and compressibility. Care will be taken not to compress or obliterate the vein by applying minimal pressure. When the whole circumference of the vein will be visible the measurements were done. The recordings will be done for four respiratory cycles. The maximum, minimum AP diameters, and cross-sectional area will be estimated and, from this, corresponding CI will be derived (Maximum diameter or cross-sectional area (CSA)-minimum diameter or CSA/maximum diameter or CSA) ×100%. All the above measurements will be repeated with the head end of patients elevated to 30° position IVC measurements The transducer will be placed in the subxiphoid region in a longitudinal position. IVC measurements will be made just distal to the IVC-hepatic vein junction, approximately 3 to 4 cm distal to the right atrium. The IVC will be identified by Doppler waveform, compressibility and phasic collapse with respiration. The maximum (IVCD) and minimum (IVCD) internal anteroposterior (AP) diameters of the IVC at the end of expiration and inspiration respectively over the same respiratory cycle will be measured. The IVCCI is derived from the equation, IVCCI= (IVCD max -IVCD min)/IVCD max × 100. The patients will be positioned in sitting position to give the spinal anesthesia at L3-L4/L2-L3 intervertebral level in the midline approach. After local infiltration of skin and subcutaneous tissue with 2% lignocaine, 25 G B-braun spinal needle will be used to administer subarachnoid block (SAB) with 2.5 ml of hyperbaric bupivacaine (5%) and 20 µg of fentanyl after confirmation of free flow of cerebrospinal fluid (CSF) at the hub of the needle. Patients will be coloaded with 10-12 ml/kg (over the period of 15 min) of Ringer's Lactate (RL) solution at the time of SAB. Thereafter, patients will be placed in supine position with wedge under the right hip. HR, systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), and SpO2 will be recorded throughout the procedure every 3 min till 15 min of SAB. Level of sensory block will be assessed by response to cold touch and surgery will be allowed after sensory blocks reaches to T6 level. Hypotension (reduction in MAP more than 20% and/or MAP <65 mmHg) will be treated with 6 mg of injection of ephedrine and a bolus of 250 ml of Ringer's Lactate (RL) solution over 10 minutes. Number of boluses of ephedrine and fluids will be recorded. Bradycardia (Heart Rate < 50 beats/ min) will be treated with 0.6 mg of injection atropine. Data collection The attending anaesthesiologist who will perform subarachnoid block (SAB) and will monitor the patient during the study period will be blinded to the ultrasound measurements of both inferior vena cava collapsibility index (IVCCI) and internal jugular vein collapsibility index (IJVCI) which will be recorded by either of the two investigators pre-operatively. Measurements: Demographic data as age, weight, height and ASA status. Hemodynamics including heart rate, mean arterial blood pressure every 3 min till 15 min of SAB. Number of boluses of ephedrine and fluids will be recorded Inferior vena cava collapsibility index (IVCCI) and internal jugular vein collapsibility index (IJVCI).

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Cesarean Section
    Keywords
    cesarean section, hypotension

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    Care Provider
    Allocation
    Randomized
    Enrollment
    55 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    US Internal Jugular Vein Collapsibility Index
    Arm Type
    Experimental
    Arm Description
    The US transducer will be placed on the right side of the neck in the transverse plane over RIJV 2 cm above the sternoclavicular joint. The IJV will be identified by the color flow Doppler and compressibility.
    Arm Title
    US Inferior Vena Cava Collapsibility Index
    Arm Type
    Experimental
    Arm Description
    The transducer will be placed in the subxiphoid region in a longitudinal position. IVC measurements will be made just distal to the IVC-hepatic vein junction, approximately 3 to 4 cm distal to the right atrium. The IVC will be identified by Doppler waveform, compressibility and phasic collapse with respiration.
    Intervention Type
    Procedure
    Intervention Name(s)
    US Internal Jugular Vein Collapsibility Index measurment
    Intervention Description
    Machine A sonosite M-Turbo ultrasound machine will be used for all the examinations. A curvilinear USG probe for IVC imaging (1-5 MHz, 21 mm). The US transducer will be placed on the right side of the neck in the transverse plane over RIJV 2 cm above the sternoclavicular joint. The IJV will be identified by the color flow Doppler and compressibility. Care will be taken not to compress or obliterate the vein by applying minimal pressure. When the whole circumference of the vein will be visible the measurements were done. The recordings will be done for four respiratory cycles. The maximum, minimum AP diameters, and cross-sectional area will be estimated and, from this, corresponding CI will be derived (Maximum diameter or cross-sectional area (CSA)-minimum diameter or CSA/maximum diameter or CSA) ×100%. All the above measurements will be repeated with the head end of patients elevated to 30° position.
    Intervention Type
    Procedure
    Intervention Name(s)
    US Inferior Vena Cava Collapsibility Index measurment
    Intervention Description
    Machine A sonosite M-Turbo ultrasound machine will be used for all the examinations. A linear vascular transuder for IJV imaging (7-13 MHz, 38 mm) will be used. The transducer will be placed in the subxiphoid region in a longitudinal position. IVC measurements will be made just distal to the IVC-hepatic vein junction, approximately 3 to 4 cm distal to the right atrium. The IVC will be identified by Doppler waveform, compressibility and phasic collapse with respiration. The maximum (IVCD) and minimum (IVCD) internal anteroposterior (AP) diameters of the IVC at the end of expiration and inspiration respectively over the same respiratory cycle will be measured. The IVCCI is derived from the equation, IVCCI= (IVCD max -IVCD min)/IVCD max × 100.
    Primary Outcome Measure Information:
    Title
    pre-operative inferior vena cava collapsibility index (IVCCI)
    Description
    for predicting post-spinal anaesthesia hypotension (PSAH). The maximum (IVCD) and minimum (IVCD) internal anteroposterior (AP) diameters of the IVC at the end of expiration and inspiration respectively over the same respiratory cycle will be measured. The IVCCI is derived from the equation, IVCCI= (IVCD max -IVCD min)/IVCD max × 100
    Time Frame
    pre-operative
    Title
    pre-operative internal jugular vein collapsibility index (IJVCI)
    Description
    for predicting post-spinal anaesthesia hypotension (PSAH), The maximum, minimum antero-pestorior diameters, and cross-sectional area will be estimated and, from this, corresponding collapsibility index will be derived (Maximum diameter or cross-sectional area (CSA)-minimum diameter or CSA/maximum diameter or CSA) ×100%.
    Time Frame
    pre-operative

    10. Eligibility

    Sex
    Female
    Gender Based
    Yes
    Minimum Age & Unit of Time
    20 Years
    Maximum Age & Unit of Time
    40 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: 1.55 female patients 2. aged 20-40 years 3.ASA Physical Status Class I and II 4. scheduled for elective lower segment cesarean section Exclusion Criteria: Patients who will refuse Emergency LSCS Patients with expected massive intraoperative blood loss e.g. placenta Previa and placenta accreta Cardiovascular, respiratory, renal diseases Patients who will receive preloading of intravenous fluid

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Pre-operative Ultrasonographic Evaluation of the Internal Jugular Vein Collapsibility Index and Inferior Vena Cava Collapsibility Index to Predict Post Spinal Hypotension in Pregnant Women Undergoing Caesarean Section

    We'll reach out to this number within 24 hrs